They help you weigh the pros and cons, ensuring that GLP-1 therapy is the right fit for your specific health needs
Discard if cloudy, discolored, or showing floating particles after 5 to 10 minutes of gentle mixing
If youve been doing the right things and still feel stuck, its normal to look for support that doesnt feel extreme
At 2 mg/mL, the 2.4 mg maintenance dose requires 1.2 mL, which exceeds a standard 1 mL insulin syringe
We offer expert legal guidance to ensure that your practice and pharmacy remain compliant with FDA regulations and are ready for any future changes
Several important considerations apply: Individuals with active or severe gastrointestinal disease may experience worsening symptoms due to the gastrointestinal side effects of GLP-1 medications The slowed gastric emptying caused by these drugs could theoretically exacerbate symptoms in people with strictures or obstructive complications of Crohn's disease Weight loss associated with GLP-1 therapy may be inappropriate in patients with Crohn's disease who are already experiencing malnutrition or unintentional weight loss The interaction between GLP-1 medications and the inflammatory processes in IBD is not fully understood Clinical decision-making should involve a thorough assessment of disease activity, nutritional status, presence of complications (such as strictures or fistulas), and the primary indication for GLP-1 therapy